Healthy volunteers help Fine-Tune ADHD drug absorption
NCT ID NCT07253441
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested how different capsule versions of the ADHD drug centanafadine are absorbed in the body. 174 healthy adults took part to see if a single high-dose capsule works the same as two lower-dose capsules, and whether food changes absorption. No treatment was given; the goal was to gather information for future manufacturing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON Lenexa
Lenexa, Kansas, 66219, United States
-
ICON Salt Lake City
Millcreek, Utah, 84124, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New ADHD drug for kids shows promise in 14-Hour classroom study
- New device aims to tame ADHD symptoms in kids without meds
- Could a magnetic helmet curb impulsivity in veterans with ADHD?
- Zapping the brain to curb cravings: new hope for dual diagnosis patients?
- ADHD may raise alcohol relapse risk, study finds
- New online program aims to ease ADHD symptoms in Moms-to-Be